WATCHMAN versus AMPLATZER Cardiac Plug: Which will prevail?

Jacqueline Saw; Taku Inohara

doi:10.4244/EIJV16I11A163

WATCHMAN versus AMPLATZER Cardiac Plug: Which will prevail?

Jacqueline Saw
, Taku Inohara

救急医学

研究成果: Review article › 査読

1 被引用数 (Scopus)

本文言語	English
ページ（範囲）	E872-E874
ジャーナル	EuroIntervention
巻	16
号	11
DOI	https://doi.org/10.4244/EIJV16I11A163
出版ステータス	Published - 2020 12月

ASJC Scopus subject areas

循環器および心血管医学

文献へのアクセス

10.4244/EIJV16I11A163

他のファイルとリンク

引用スタイル

@article{64d5591694ef45e0952d019c1b45c0f6,

title = "WATCHMAN versus AMPLATZER Cardiac Plug: Which will prevail?",

author = "Jacqueline Saw and Taku Inohara",

note = "Funding Information: J. Saw has received unrestricted research grant support (from the Canadian Institutes of Health Research, Heart \& Stroke Foundation of Canada, National Institutes of Health, University of British Columbia Division of Cardiology, AstraZeneca, Abbott Vascular, St. Jude Medical, Boston Scientific, and Servier), salary support (Michael Smith Foundation of Health Research), speaker honoraria (AstraZeneca, Abbott Vascular, Boston Scientific, and Sunovion), consultancy and advisory board honoraria (AstraZeneca, St. Jude Medical, Abbott Vascular, Boston Scientific, Baylis, Gore, FEops), and proctorship honoraria (Abbott Vascular, St. Jude Medical and Boston Scientific). The other author has no conflicts of interest to declare.",

year = "2020",

month = dec,

doi = "10.4244/EIJV16I11A163",

language = "English",

volume = "16",

pages = "E872--E874",

journal = "EuroIntervention",

issn = "1774-024X",

publisher = "Europa Group",

number = "11",

}

TY - JOUR

T1 - WATCHMAN versus AMPLATZER Cardiac Plug

T2 - Which will prevail?

AU - Saw, Jacqueline

AU - Inohara, Taku

N1 - Funding Information: J. Saw has received unrestricted research grant support (from the Canadian Institutes of Health Research, Heart & Stroke Foundation of Canada, National Institutes of Health, University of British Columbia Division of Cardiology, AstraZeneca, Abbott Vascular, St. Jude Medical, Boston Scientific, and Servier), salary support (Michael Smith Foundation of Health Research), speaker honoraria (AstraZeneca, Abbott Vascular, Boston Scientific, and Sunovion), consultancy and advisory board honoraria (AstraZeneca, St. Jude Medical, Abbott Vascular, Boston Scientific, Baylis, Gore, FEops), and proctorship honoraria (Abbott Vascular, St. Jude Medical and Boston Scientific). The other author has no conflicts of interest to declare.

PY - 2020/12

Y1 - 2020/12

UR - https://www.scopus.com/pages/publications/85097121965

UR - https://www.scopus.com/pages/publications/85097121965#tab=citedBy

U2 - 10.4244/EIJV16I11A163

DO - 10.4244/EIJV16I11A163

M3 - Review article

C2 - 33274724

AN - SCOPUS:85097121965

SN - 1774-024X

VL - 16

SP - E872-E874

JO - EuroIntervention

JF - EuroIntervention

IS - 11

ER -